New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy
**Note: the release below is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID ...